RARENasdaq United States
Market cap
$2.554 B
$25.91 +0.35%
Close of 7 Aug 2026
Revenue
$673.0M
#1759 by revenue
Earnings
-$575.0M
Loss-making
Shares outstanding
98,588,873
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ultragenyx Pharmaceutical are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.